Fresenius Kabi

Indications

Intestamin® is indicated for patients with limited enteral tolerance and in need of early enteral high glutamine and antioxidant supply.

  • Post-surgery, post trauma patients at risk of severe SIRS and sepsis including
    • Malnourished patients
    • Patients with major abdominal surgery
    • Patients with severe blunt or penetrating torso trauma
  • Critically ill patients with severe SIRS or sepsis

Notes:
  • To be used under medical supervision.
  • Not suitable for children < 10 years.
  • Not for parenteral use.
  • The vitamin E content of Intestamin may enhance the effects of anticoagulation therapy in particular the effects of vitamin K antagonists. Regular control of coagulation is recommended.
  • The vitamin C content of Intestamin may
    • influence urine analysis
    • promote iron absorption, which has to be taken into account in patients with iron storage diseases.
    • increase urinary oxalate excretion which after prolonged application could result in oxalate stone formation in patients at high risk, e.g. with a history of stone formation.